217 related articles for article (PubMed ID: 32343351)
1. Association of the US Food and Drug Administration Antipsychotic Drug Boxed Warning With Medication Use and Health Outcomes in Elderly Patients With Dementia.
Rubino A; Sanon M; Ganz ML; Simpson A; Fenton MC; Verma S; Hartry A; Baker RA; Duffy RA; Gwin K; Fillit H
JAMA Netw Open; 2020 Apr; 3(4):e203630. PubMed ID: 32343351
[TBL] [Abstract][Full Text] [Related]
2. National antidepressant prescribing in children and adolescents with mental health disorders after an FDA boxed warning.
Mittal M; Harrison DL; Miller MJ; Brahm NC
Res Social Adm Pharm; 2014; 10(5):781-90. PubMed ID: 24355381
[TBL] [Abstract][Full Text] [Related]
3. Impact of FDA Black Box Warning on Psychotropic Drug Use in Noninstitutionalized Elderly Patients Diagnosed With Dementia: A Retrospective Study.
Singh RR; Nayak R
J Pharm Pract; 2016 Oct; 29(5):495-502. PubMed ID: 25917167
[TBL] [Abstract][Full Text] [Related]
4. Impact of FDA black box advisory on antipsychotic medication use.
Dorsey ER; Rabbani A; Gallagher SA; Conti RM; Alexander GC
Arch Intern Med; 2010 Jan; 170(1):96-103. PubMed ID: 20065205
[TBL] [Abstract][Full Text] [Related]
5. Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration.
Sankar A; Swanson KM; Zhou J; Jena AB; Ross JS; Shah ND; Karaca-Mandic P
JAMA Netw Open; 2021 Dec; 4(12):e2136662. PubMed ID: 34851398
[TBL] [Abstract][Full Text] [Related]
6. The impact of FDA's warning on the use of antipsychotics in clinical practice: a survey.
Saad M; Cassagnol M; Ahmed E
Consult Pharm; 2010 Nov; 25(11):739-44. PubMed ID: 21138822
[TBL] [Abstract][Full Text] [Related]
7. Association of the Centers for Medicare & Medicaid Services' National Partnership to Improve Dementia Care With the Use of Antipsychotics and Other Psychotropics in Long-term Care in the United States From 2009 to 2014.
Maust DT; Kim HM; Chiang C; Kales HC
JAMA Intern Med; 2018 May; 178(5):640-647. PubMed ID: 29550856
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.
Cowart K; Worley M; Rouby NE; Sando K
Ann Pharmacother; 2019 Dec; 53(12):1192-1199. PubMed ID: 31319681
[No Abstract] [Full Text] [Related]
9. Antipsychotic drug use since the FDA black box warning: survey of nursing home policies.
Lester P; Kohen I; Stefanacci RG; Feuerman M
J Am Med Dir Assoc; 2011 Oct; 12(8):573-577. PubMed ID: 21450177
[TBL] [Abstract][Full Text] [Related]
10. Prescribing Antipsychotic Medications to Patients With Dementia: Boxed Warnings and Mitigation of Legal Liability.
Rose RV; Kass JS
Continuum (Minneap Minn); 2019 Feb; 25(1):254-259. PubMed ID: 30707196
[TBL] [Abstract][Full Text] [Related]
11. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation.
Multinu F; Casarin J; Hanson KT; Angioni S; Mariani A; Habermann EB; Laughlin-Tommaso SK
JAMA Surg; 2018 Jun; 153(6):e180141. PubMed ID: 29641835
[TBL] [Abstract][Full Text] [Related]
12. Trends in the prescribing of atypical antipsychotics in elderly patients with dementia in Korea
.
Seo N; Song I; Park H; Ha D; Shin JY
Int J Clin Pharmacol Ther; 2017 Jul; 55(7):581-587. PubMed ID: 28372635
[TBL] [Abstract][Full Text] [Related]
13. Trends in antipsychotic use in dementia 1999-2007.
Kales HC; Zivin K; Kim HM; Valenstein M; Chiang C; Ignacio RV; Ganoczy D; Cunningham F; Schneider LS; Blow FC
Arch Gen Psychiatry; 2011 Feb; 68(2):190-7. PubMed ID: 21300946
[TBL] [Abstract][Full Text] [Related]
14. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.
Bratsman A; Mathias K; Laubscher R; Grigoryan L; Rose S
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):701-707. PubMed ID: 32390266
[TBL] [Abstract][Full Text] [Related]
15. Trends in Incident Varenicline Prescribing Among Veterans Following the US Food and Drug Administration Drug Safety Warnings.
Gerlach LB; Van T; Kim HM; Chang MM; Bohnert KM; Zivin K
J Clin Psychiatry; 2021 Dec; 83(1):. PubMed ID: 34936245
[No Abstract] [Full Text] [Related]
16. Coprescribing of opioids and high-risk medications in the USA: a cross-sectional study with data from national ambulatory and emergency department settings.
Suvada K; Zimmer A; Soodalter J; Malik JS; Kavalieratos D; Ali MK
BMJ Open; 2022 Jun; 12(6):e057588. PubMed ID: 35710252
[TBL] [Abstract][Full Text] [Related]
17. Inappropriate medication prescribing for the elderly by office-based physicians.
Aparasu RR; Fliginger SE
Ann Pharmacother; 1997; 31(7-8):823-9. PubMed ID: 9220038
[TBL] [Abstract][Full Text] [Related]
18. After the black box warning: predictors of psychotropic treatment choices for older patients with dementia.
Kim HM; Chiang C; Kales HC
Psychiatr Serv; 2011 Oct; 62(10):1207-14. PubMed ID: 21969648
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis.
Yunusa I; Alsumali A; Garba AE; Regestein QR; Eguale T
JAMA Netw Open; 2019 Mar; 2(3):e190828. PubMed ID: 30901041
[TBL] [Abstract][Full Text] [Related]
20. Physician Antipsychotic Overprescribing Letters and Cognitive, Behavioral, and Physical Health Outcomes Among People With Dementia: A Secondary Analysis of a Randomized Clinical Trial.
Harnisch M; Barnett ML; Coussens S; Thomas KS; Olfson M; Berhane K; Sacarny A
JAMA Netw Open; 2024 Apr; 7(4):e247604. PubMed ID: 38662373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
